Cargando…
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression
MiR-182 expression was evaluated by qRT-PCR and in situ hybridization in 20 tubular adenomas, 50 colorectal carcinoma (CRC), and 40 CRC liver metastases. Control samples obtained from patients with irritable bowel syndrome, or tumor-matched normal colon mucosa were analyzed (n=50). MiR-182 expressio...
Autores principales: | Perilli, Lisa, Vicentini, Caterina, Agostini, Marco, Pizzini, Silvia, Pizzi, Marco, D'Angelo, Edoardo, Bortoluzzi, Stefania, Mandruzzato, Susanna, Mammano, Enzo, Rugge, Massimo, Nitti, Donato, Scarpa, Aldo, Fassan, Matteo, Zanovello, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196150/ https://www.ncbi.nlm.nih.gov/pubmed/25115394 |
Ejemplares similares
-
Human miRNome profiling in colorectal cancer and liver metastasis development
por: Perilli, Lisa, et al.
Publicado: (2014) -
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis
por: Pizzini, Silvia, et al.
Publicado: (2013) -
Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer
por: Perilli, Lisa, et al.
Publicado: (2019) -
Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma
por: D'Angelo, Edoardo, et al.
Publicado: (2016) -
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract
por: Vicentini, Caterina, et al.
Publicado: (2014)